Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and... see more

TSX:WELL - Post Discussion

WELL Health Technologies Corp > Q2 Positives & Negatives summary
View:
Post by ahsh1kah on Aug 14, 2024 10:54am

Q2 Positives & Negatives summary

Positive
 
- Record quarterly revenue of $243.1 million, a 42% increase YoY.
- Adjusted EBITDA increased by 11% to $30.9 million.
- 1.4 million patient visits, a 38% increase YoY.
- U.S. digital revenues rose by 40% to $56.3 million.
- Raised annual revenue forecast to $970 million to $990 million.
- Generated $35.2 million in operating cash flow.
- Paid down $14 million in debt.
 
Negative
 
- Adjusted Gross Margin declined to 44.2% from 53.1%
- Adjusted Net Income decreased to $12.3 million from $14.4 million.
- Free cash flow attributable to shareholders decreased to $8.7 million from $9.4 million.

 (Per the release, the declines is attributed to the acquisition of businesses in the past year that had lower gross margin percentage)
Comment by Speedyg5344 on Aug 14, 2024 11:05am
Hopefully Hamid provides some uplifting colour on the monetization of its USA assets. An injection  of 2 2 to 4 hundred million Candian dollars for its interest in Circle should juice the share price notwiothstanding the revenue  loss. Circle's run rate of 137 million Canadian $ should price the entire busines at  roughly 600 million...thoughts? The quarterly reports ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities